Intravenous granisetron attenuates hypotension during spinal anesthesia in cesarean delivery: A double-blind, prospective randomized controlled study
- PMID: 26330710
- PMCID: PMC4541178
- DOI: 10.4103/0970-9185.161667
Intravenous granisetron attenuates hypotension during spinal anesthesia in cesarean delivery: A double-blind, prospective randomized controlled study
Abstract
Background and aims: This study was conducted to determine the effectiveness of intravenous (IV) granisetron in the prevention of hypotension and bradycardia during spinal anesthesia in cesarean delivery.
Material and methods: A total of 200 parturients scheduled for elective cesarean section were included in this study. They were randomly divided into two groups. Group I was given 1 mg granisetron diluted in 10 ml normal saline slowly IV, 5 min before spinal anesthesia. Group II was given 10 ml of normal saline, 5 min before spinal anesthesia. Mean arterial blood pressure and heart rate (HR) were recorded every 3 min until the end of surgery (for 45 min). The total consumption of vasopressors and atropine were recorded. Apgar scores at 1 and 5 min were also assessed.
Results: Serial mean arterial blood pressure and HR values for 45 min after onset of spinal anesthesia were decreased significantly in group II, P < 0.0001. The incidence of hypotension after spinal anesthesia was 64% in group II and 3% in group I (P < 0.0001). The total doses of ephedrine (4.07 ± 3.87 mg vs 10.7 ± 8.9 mg, P < 0.0001), phenylephrine (0.0 microg vs 23.2 ± 55.1 microg, P < 0.0001), and atropine (0.0 mg vs 0.35 ± 0.49 mg P < 0.0001) consumed in both the groups respectively, were significantly less in group I versus group II.
Conclusion: Premedication with 1 mg IV granisetron before spinal anesthesia in an elective cesarean section significantly reduces hypotension, bradycardia and vasopressors usage.
Keywords: Cesarean; granisetron; hypotension; spinal anesthesia.
Conflict of interest statement
Figures
References
-
- Carpenter RL, Caplan RA, Brown DL, Stephenson C, Wu R. Incidence and risk factors for side effects of spinal anesthesia. Anesthesiology. 1992;76:906–16. - PubMed
-
- Arndt JO, Bömer W, Krauth J, Marquardt B. Incidence and time course of cardiovascular side effects during spinal anesthesia after prophylactic administration of intravenous fluids or vasoconstrictors. Anesth Analg. 1998;87:347–54. - PubMed
-
- Norris MC. Spinal anesthesia for cesarean delivery. In: Norris MC, editor. Handbook of Obstetric Anesthesia. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2000. pp. 309–12.
-
- Butterworth J. Physiology of spinal anesthesia: What are the implications for management? Reg Anesth Pain Med. 1998;23:370–3. - PubMed
-
- Adams VR, Valley AW. Granisetron: The second serotonin-receptor antagonist. Ann Pharmacother. 1995;29:1240–51. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
